Drug Markets/Asenapine

Asenapine

10 NDCs across 3 manufacturers|7 Generic,3 Brand

Asenapine is used to treat bipolar disorder and schizophrenia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Oct 11, 2019. In 2024, Medicare Part D spent $6 million on Asenapine across 4,499 claims for 873 beneficiaries.

Asenapine is available as 10 NDCs from 3 manufacturers (7 generic, 3 brand), with NADAC prices from $2.15 to $49.17 per EAthe most expensive product costs about 23× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

10

7G / 3B

Manufacturers

3

competing in market

Price Spread

$2.15 – $49.17

per EA

7d Activity

262 flat

avg -4.0% WoW · of 10 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

10 NDCs total, 10 shown

Frequently Asked Questions

What is Asenapine used to treat?

Asenapine is used to treat bipolar disorder and schizophrenia, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Asenapine?

In 2024, Medicare Part D spent $6 million on Asenapine across 4,499 claims for 873 beneficiaries.

How many Asenapine products are on the market?

The Asenapine drug market contains 10 NDCs from 3 manufacturers — 7 generic and 3 brand products.

What is the price range for Asenapine?

NADAC reference prices for Asenapine range from $2.1475 to $49.1749 per EA — the most expensive product costs about 23× the cheapest.

Is generic Asenapine cheaper than brand?

The average generic NADAC for Asenapine is $2.6194 per EA, versus $49.0781 for brand-labeled products — brand versions average about 19× the generic price.

Which manufacturers make Asenapine?

3 manufacturers list Asenapine in NADAC. Ranked by number of NDCs, the largest are Alembic Pharmaceuticals Inc. (5), Noven Therapeutics, LLC (3), Sigmapharm Laboratories LLC (2).

How has the price of Asenapine changed recently?

Over the past 7 days, 2 Asenapine NDCs rose and 6 fell, with a market-wide average change of -4.0%.